Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are...
Main Authors: | Sabrina Bochicchio, Gaetano Lamberti, Anna Angela Barba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/198 |
Similar Items
-
Cartilage‐targeting ultrasmall lipid‐polymer hybrid nanoparticles for the prevention of cartilage degradation
by: Xiangzhao Ai, et al.
Published: (2021-01-01) -
Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
by: Mukherjee A, et al.
Published: (2019-03-01) -
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
by: Tahir N, et al.
Published: (2019-07-01) -
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
by: Ayeskanta Mohanty, et al.
Published: (2020-09-01) -
Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer
by: Wang Z, et al.
Published: (2020-03-01)